-
April 19, 2013
Speculation has been all over the place for an M&A with LifeTech, but the final announcement is consistent with my ...
-
April 17, 2013
Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
-
February 13, 2013
Roche (RHHBY) recently entered into a drug discovery collaboration with privately-held RQx Pharmaceuticals, Inc. ...
-
February 11, 2013
Genetic products company, Affymetrix Inc. (AFFX), inked a 'Powered by Affymetrix' ("PbA") Program agreement with ...
-
February 08, 2013
Alnylam Pharmaceuticals Inc.'s (ALNY) fourth quarter 2012 loss of $1.20 per share was narrower than the Zacks ...
-
February 01, 2013
Roche Holdings Ltd. (RHHBY) recently reported 2012 results. Revenues grew 4% year over year to CHF 45.5 billion ...
-
February 01, 2013
Merck & Co. (MRK) reported fourth quarter 2012 earnings per share (excluding special items) of 83 cents, a couple of ...
-
January 31, 2013
Endocyte Inc. (ECYT) recently announced that its oncology candidate, EC0652, achieved key objectives in a phase 0 ...
-
January 30, 2013
Roche (RHHBY) announced that its wholly owned subsidiary, Genentech, has recently inked a global licensing agreement ...
-
January 28, 2013
Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of Merck & Co's (MRK) Singulair ...
-
January 28, 2013
ImmunoGen Inc. (IMGN) reported second quarter fiscal 2013 adjusted loss of 29 cents per share, wider than both the ...
-
January 24, 2013
The US Food and Drug Administration (FDA) recently approved Roche's (RHHBY) Avastin (bevacizumab) in combination ...
-
January 18, 2013
Exelixis, Inc. (EXEL) recently announced that it has received a notice from its partner, Roche Holding (RHHBY), ...
-
January 17, 2013
Astellas Pharmaceuticals Inc. (ALPMY) recently announced that the US Food and Drug Administration (FDA) has accepted ...
-
January 14, 2013
ArQule Inc. (ARQL) and partner Daiichi Sankyo recently announced disappointing phase II results on oncology ...
-
January 07, 2013
Roche may have walked away from Illumina for good.
-
December 28, 2012
Bayer Yakuhin Ltd., the Japanese subsidiary of Bayer AG (BAYRY), submitted a marketing authorization application for ...
-
December 24, 2012
Switzerland based Roche (RHHBY) recently announced that the US Food and Drug Administration (FDA) has approved ...
-
December 21, 2012
Once again the buyout rumor of Illumina Inc. (ILMN) by Swiss drug maker Roche Holding AG (RHHBY) cheered the ...
-
December 13, 2012
Sanofi (SNY) recently announced positive results from a phase II trial evaluating the efficacy of its hematology ...
